Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia

Leukemia
A ArgirisJ R Bertino

Abstract

Acute myelocytic leukemia (AML) is a malignancy that is intrinsically resistant to methotrexate (MTX). AML blasts, when incubated with radiolabeled MTX, form lower amounts of long chain polyglutamates compared to acute lymphocytic leukemia (ALL) blasts, thus providing an explanation for their lack of responsiveness to MTX. Leukemic blasts obtained from two children with acute megakaryocytic leukemia (M7 subtype) when incubated with radiolabeled MTX showed increased accumulation of total as well as long chain MTX polyglutamates, comparable to levels previously demonstrated in another subtype of AML, acute monocytic leukemia (M5), as well as in blasts from patients with pre-B ALL. We suggest that M7-AML patients with blasts showing increased MTX polyglutamylation might benefit from treatment with MTX.

Citations

Mar 3, 2007·Cancer Metastasis Reviews·Yehuda G Assaraf
Jul 10, 1998·Immunology Letters·D C Kilpatrick
May 22, 2003·Journal of Pediatric Hematology/oncology·Jeffrey A ToretskyJudith Stamberg
Apr 21, 2009·Blood·Steven M CorselloKimberly Stegmaier
Mar 27, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M G RotsG J Peters
Jan 6, 2004·International Journal of Hematology·R Pieters, M L den Boer
Feb 26, 2008·Leukemia & Lymphoma·Alan Kambiz Fotoohi, Freidoun Albertioni
Mar 14, 2007·Cancer Genetics and Cytogenetics·Norio ShibaAkihiro Morikawa
Oct 25, 2003·Oncogene·Rongbao Zhao, I David Goldman
Mar 28, 2003·Oncogene·Sandrine LacourMarie-Thérèse Dimanche-Boitrel
Oct 7, 2005·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Kim Robien
Mar 16, 2012·Future Medicinal Chemistry·Olga Grzybowska-Izydorczyk, Piotr Smolewski
Mar 13, 2021·Leukemia·Martha M ZarouG Vignir Helgason

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.